INVO Fertility (IVF) Operating Income Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -5.23% |
| Jun 30, 2025 | -22.98% |
| Mar 31, 2025 | -65.05% |
| Dec 31, 2024 | 41.70% |
| Sep 30, 2024 | -15.51% |
| Jun 30, 2024 | -94.95% |
| Mar 31, 2024 | -34.00% |
| Dec 31, 2023 | -24.05% |
| Sep 30, 2023 | -36.09% |
| Jun 30, 2023 | -2.90% |
| Mar 31, 2023 | -75.06% |
| Dec 31, 2022 | 98.68% |
| Sep 30, 2022 | -77.26% |
| Jun 30, 2022 | -82.52% |
| Mar 31, 2022 | -74.55% |
| Dec 31, 2021 | 78.49% |
| Sep 30, 2021 | -61.43% |
| Jun 30, 2021 | -5.37% |
| Mar 31, 2021 | -53.90% |
| Dec 31, 2020 | -49.80% |
| Sep 30, 2020 | -60.57% |
| Jun 30, 2020 | -58.15% |
| Mar 31, 2020 | -60.32% |
| Dec 31, 2019 | 10.60% |
| Sep 30, 2019 | -43.29% |
| Jun 30, 2019 | 17.66% |
| Mar 31, 2019 | -27.29% |
| Dec 31, 2018 | -29.76% |
| Sep 30, 2018 | -8.83% |
| Jun 30, 2018 | -64.22% |
| Mar 31, 2018 | 6.03% |
| Dec 31, 2017 | -11.26% |
| Sep 30, 2017 | 2.08% |
| Jun 30, 2017 | 3.71% |
| Mar 31, 2017 | -7.44% |
| Dec 31, 2016 | -12.15% |
| Sep 30, 2016 | -3.75% |
| Jun 30, 2016 | -47.99% |